AdaptHealth (AHCO) Net Income towards Common Stockholders (2018 - 2026)

AdaptHealth's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$14.9 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 144.66% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$74.9 million (down 183.33% YoY), while the FY2025 annual figure was -$66.1 million, down 169.66% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$14.9 million, up from -$101.6 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $51.4 million in Q4 2024, with the low at -$452.9 million in Q3 2023.
• The 5-year median for Net Income towards Common Stockholders is $14.8 million (2022), against an average of -$35.1 million.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders surged 1063.51% in 2022, then sank 15381.01% in 2023.
• AdaptHealth's Net Income towards Common Stockholders stood at -$1.6 million in 2022, then tumbled by 15381.01% to -$253.6 million in 2023, then surged by 120.27% to $51.4 million in 2024, then slumped by 297.61% to -$101.6 million in 2025, then surged by 85.36% to -$14.9 million in 2026.
• Business Quant data shows AHCO's Net Income towards Common Stockholders at -$14.9 million in Q1 2026, -$101.6 million in Q4 2025, and $25.8 million in Q3 2025.